14/05/2024 |
IRLAB Therapeutics AB |
Gunnar Olof Olsson |
Chief Executive Officer (CEO)/Managing Directory |
|
Acquisition |
IRL |
Share |
SE0012675361 |
14/05/2024 |
2,000 |
Quantity |
15.50 |
SEK |
|
Notification
|
13/05/2024 |
IRLAB Therapeutics AB |
Viktor Siewertz |
Chief Financial Officer (CFO) |
|
Acquisition |
IRLAB Therapeutics AB ser. A |
Share |
SE0012675361 |
13/05/2024 |
5,000 |
Quantity |
13.6074 |
SEK |
|
Notification
|
10/05/2024 |
IRLAB Therapeutics AB |
Daniel Johnsson |
Member of the Board of Directors |
|
Acquisition |
IRLAB Therapeutics Ab Serie A |
Share |
SE0012675361 |
10/05/2024 |
20,000 |
Quantity |
12.984 |
SEK |
|
Notification
|
05/04/2023 |
IRLAB Therapeutics AB |
Joakim Tedroff |
Other senior executive |
Yes |
Acquisition |
IRLAB Therapeutics AB ser. A |
Share |
SE0012675361 |
03/04/2023 |
51,430 |
Quantity |
39.64 |
SEK |
|
Notification
|
28/02/2023 |
IRLAB Therapeutics AB |
Cecilia Tivert Stenberg |
Chief Financial Officer (CFO) |
|
Disposal |
IRLAB BTA A |
Share |
SE0013748332 |
28/02/2023 |
20,000 |
Quantity |
10.90 |
SEK |
|
Notification
|
05/09/2022 |
IRLAB Therapeutics AB |
Richard Godfrey |
Chief Executive Officer (CEO)/Managing Directory |
Yes |
Acquisition |
IRLAB Therapeutics AB ser. A |
Share |
SE0012675361 |
01/09/2022 |
5,000 |
Quantity |
34.8914 |
SEK |
|
Notification
|
30/08/2022 |
IRLAB Therapeutics AB |
Viktor Siewertz |
Chief Financial Officer (CFO) |
Yes |
Disposal |
IRLAB Therapeutics AB ser. A |
Share |
SE0012675361 |
29/08/2022 |
40 |
Quantity |
35.20 |
SEK |
|
Notification
|
30/08/2022 |
IRLAB Therapeutics AB |
Viktor Siewertz |
Chief Financial Officer (CFO) |
Yes |
Acquisition |
IRLAB Therapeutics AB ser. A |
Share |
SE0012675361 |
30/08/2022 |
40 |
Quantity |
35.50 |
SEK |
|
Notification
|
16/07/2022 |
IRLAB Therapeutics AB |
Joakim Tedroff |
Other senior executive |
|
Division of joint property between spouses decrease |
IRLAB THERAPEUTICS A |
Share |
SE0012675361 |
15/07/2022 |
84,148 |
Quantity |
0.00 |
SEK |
|
Notification
|
31/05/2022 |
IRLAB Therapeutics AB |
Viktor Siewertz |
Chief Financial Officer (CFO) |
|
Acquisition |
IRLAB Therapeutics AB ser. A |
Share |
SE0012675361 |
27/05/2022 |
3,000 |
Quantity |
38.93 |
SEK |
|
Notification
|